22157.jpg
Biomanufacturing Market Global Report 2024: Key Technologies, Market Trends and Growth Projections from 2025 to 2035
August 19, 2024 10:04 ET | Research and Markets
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Market for Industrial Biomanufacturing 2025-2035" report has been added to ResearchAndMarkets.com's offering. Industrial biomanufacturing...
Dyadic Logo Current.jpg
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 13, 2024 16:05 ET | Dyadic International, Inc.
Alternative Proteins Entered into a development and commercialization partnership for the sale of animal-free recombinant albumin products with Proliant Health and BiologicalsEntered into a joint...
Global Cell Therapy Biomanufacturing Market
Cell Therapy Biomanufacturing Market Report 2024: Market Revenue Data from 2022, Estimates for 2023, Forecasts for 2024 and Projected CAGRs through 2029
August 09, 2024 05:41 ET | Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Biomanufacturing Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. The cell therapy biomanufacturing global...
LogoLightBackground.png
Capra Biosciences Lands $7.5 Million Project Agreement To Demonstrate Platform To Rapidly Scale Pharmaceutical Ingredient Manufacturing
July 19, 2024 10:00 ET | Capra Biosciences
Capra Biosciences to demonstrate biochemical production of pharmaceutical ingredient manufacturing at scale
BHIANT Logo.png
Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas
July 15, 2024 11:57 ET | BHIANT
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
July 11, 2024 08:00 ET | Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
A design rendering of the Critical Medicines Production Centre
API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines
June 20, 2024 10:30 ET | Applied Pharmaceutical Innovation (API)
Construction is set to begin on a pharmaceutical manufacturing facility that will provide Canadians with access to a secure supply of critical medicines.
Dyadic Logo Current.jpg
Dyadic to Attend Industry Events in June
May 30, 2024 16:30 ET | Dyadic International, Inc.
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
May 28, 2024 07:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
22157.jpg
The Global Biomanufacturing Market 2024-2035 - Exploring the Rapidly Evolving Landscape of Biomanufacturing Technologies and Applications
May 27, 2024 04:30 ET | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Biomanufacturing Market 2024-2035" report has been added to ResearchAndMarkets.com's offering. The Global Biomanufacturing Markets 2024-2035...